Skip to main content

Marsh’s Q1 Earnings Call: Our Top 5 Analyst Questions

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

MRSH Cover Image

Marsh’s first quarter results were met with a positive market reaction, reflecting strong top-line growth and the company’s ability to navigate challenging insurance pricing environments. Management credited the quarter’s momentum to robust client demand, sequential improvement in Marsh Risk, and increasing traction for AI-driven services. CEO John Doyle emphasized that recent leadership changes were made to “enhance the client experience and help us capture the benefits of Thrive,” Marsh’s efficiency and growth initiative. The company remained resilient in the face of declining insurance rates and global macro uncertainty, with adjusted operating income and non-GAAP EPS both up year over year.

Is now the time to buy MRSH? Find out in our full research report (it’s free for active Edge members).

Marsh (MRSH) Q1 CY2026 Highlights:

  • Revenue: $7.60 billion vs analyst estimates of $7.38 billion (7.6% year-on-year growth, 2.9% beat)
  • Adjusted EPS: $3.29 vs analyst estimates of $3.22 (2.1% beat)
  • Adjusted EBITDA: $2.50 billion vs analyst estimates of $2.48 billion (32.9% margin, 1.1% beat)
  • Operating Margin: 23.1%, down from 28.4% in the same quarter last year
  • Organic Revenue rose 4% year on year (beat)
  • Market Capitalization: $84.55 billion

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Marsh’s Q1 Earnings Call

  • Charles Peters (Raymond James) asked about the sustainability of margin expansion amid high results and AI’s potential to disrupt the business. CEO John Doyle emphasized continued efficiency gains from AI and Thrive, noting Marsh’s trusted client relationships and data scale as key defenses against disintermediation.
  • Michael Zaremski (BMO) inquired about AI’s value-add for client services and hiring trends. John Doyle and business heads described new AI-enabled tools like Claims IQ, which have improved sales velocity and allowed for more tailored risk analysis, while adding that hiring of producer talent remains strong.
  • Brian Meredith (UBS) questioned whether productivity gains from AI will be retained by Marsh or competed away. Doyle responded that Marsh’s advisory model and stable fee structure position it to capture the benefits, as fees remain a small portion of clients’ overall risk costs.
  • Robert Cox (Goldman Sachs) asked if AI is reshaping M&A strategy and about MMA’s role in organic growth. Doyle noted that Marsh’s scale in AI investment could enable future consolidation of smaller brokers, and MMA remains a consistent growth driver, especially in stable middle-market pricing environments.
  • Elyse Greenspan (Wells Fargo) focused on Guy Carpenter’s near-term growth outlook and capital deployment balance. Doyle and McGivney acknowledged soft reinsurance markets and guided to continued discipline in balancing M&A and share repurchases, with the AltamarCAM acquisition pending.

Catalysts in Upcoming Quarters

In the coming quarters, the StockStory team will be monitoring (1) the pace and measurable impact of Marsh’s proprietary AI product rollouts across risk and consulting segments, (2) evidence of sustained margin expansion despite persistent insurance and reinsurance pricing declines, and (3) the closing and integration of the AltamarCAM acquisition into the investments business. Additional indicators will include new business growth in MMA and the effectiveness of the Thrive program in delivering cost savings and reinvestment outcomes.

Marsh currently trades at $172.47, down from $174.90 just before the earnings. Is there an opportunity in the stock?The answer lies in our full research report (it’s free).

The Best Stocks for High-Quality Investors

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it's flagging for this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  255.36
+0.00 (0.00%)
AAPL  273.17
+0.00 (0.00%)
AMD  303.46
+0.00 (0.00%)
BAC  53.12
+0.00 (0.00%)
GOOG  337.73
+0.00 (0.00%)
META  674.72
+0.00 (0.00%)
MSFT  432.92
+0.00 (0.00%)
NVDA  202.50
+0.00 (0.00%)
ORCL  187.50
+0.00 (0.00%)
TSLA  387.51
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.